Clinical trial

Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients

NCT01652664

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Travoprost 0.004% PQ ophthalmic solution Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Timolol, 0.5% or 0.25% ophthalmic solution Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Travoprost Vehicle Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-09-01

PhasePHASE3

Conditions

Pediatric Glaucomaunresolved

Elevated IOP in Pediatric Patientsunresolved

Ocular Hypertension in Pediatric Patientsunresolved

Interventions

Travoprost 0.004% PQ ophthalmic solutionDRUG

Timolol, 0.5% or 0.25% ophthalmic solutionDRUG

Travoprost VehicleDRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01652664 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.